The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer

The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer

Abstract Background Common treatments for metastatic/unresectable HER2‐negative gastric cancer include chemotherapy, immune checkpoint inhibitor monotherapy and chemotherapy plus immune checkpoint inhibitor. However, significant drug resistance exists regardless of the treatment regimen. Methods Pat...

Full description

Bibliographic Details
Main Authors: Zihan Han, Siyuan Cheng, Die Dai, Yan Kou, Xiaotian Zhang, Fang Li, Xiaochen Yin, Jingjing Ji, Zhikuan Zhang, Xi Wang, Ning Zhu, Qi Zhang, Yan Tan, Xiaohuan Guo, Lin Shen, Zhi Peng
Format: Article
Language:English
Published: Wiley 2023-07-01
Series:Clinical and Translational Medicine
Subjects:
chemotherapy
gastric cancer
gut microbiome
immunotherapy
Online Access:https://doi.org/10.1002/ctm2.1312

Internet

https://doi.org/10.1002/ctm2.1312

Similar Items